TY  - CHAP
M1  - Book, Section
TI  - Human Papillomavirus
A1  - Gargano, Julia W.
A1  - Markowitz, Lauri E.
A2  - Boulton, Matthew L.
A2  - Wallace, Robert B.
Y1  - 2022
N1  - 
T2  - Maxcy-Rosenau-Last Public Health & Preventive Medicine, 16e
AB  - Advances  in  virology  during  the  1970s  established  the  existence  of  multiple  distinct  types  of  human  papillomavirus  (HPV).  These  virologic  discoveries,  when  combined  with  epidemiologic  studies,  and  the  recognition  that  viral  DNA  can  be  integrated  into  the  host  genome,  enabled  the  eventual  identification  of  the  causal  role  of  specific  HPV  types  in  cervical  cancers  and  later  other  cancers,  as  well  as  anogenital  warts  and  recurrent  respiratory  papillomatosis  (RRP).1,2  These  advances  and  the  identification  of  HPV  types  16  and  18  in  the  majority  of  cervical  cancers,  as  well  as  in  precancers,  later  led  to  the  development  of  prophylactic  HPV  vaccines;  this  work  was  recognized  with  a  portion  of  the  2008  Nobel  Prize  in  Physiology  or  Medicine  for  Harald  zur  Hausen.1,3  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1182675952
ER  -